bioRxiv/medRxiv TRiP Review Activity

438 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 28: Articles 271-280  | Next

Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors
Goebel, L., Kirschner, T., Koska, S., Rai, A., Janning, P., Maffini, S., Vatheuer, H., Czodrowski, P., Goody, R. S., Mueller, M. P., Rauh, D.
10.1101/2022.07.25.501348 — Posted: 2022-07-25 — Discussion: 2023-01-26  eLife
Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1
Zhang, R., Liu, Q., Zhou, S., He, H., Zhao, M., Ma, W.
10.1101/2022.09.21.508926 — Posted: 2022-09-22 — Discussion: 2023-01-26  eLife
Extracellular ATP drives pancreatic cancer cell invasion via purinergic receptor-integrin interactions
Tomas Bort, E., Joseph, M., Wang, Q., Carter, E., Roth, N., Gibson, J., Samadi, A., Kocher, H., Simoncelli, S., McCormick, P. J., Grose, R. P.
10.1101/2022.10.24.513477 — Posted: 2022-10-24 — Discussion: 2023-01-19  Review Commons
A chronic signaling TGFb zebrafish reporter identifies immune response in melanoma
Noonan, H. R., Barbano, J., Xifaras, M., Baron, C. S., Yang, S., Koczirka, K., McConnell, A. M., Zon, L. I.
10.1101/2022.09.29.510035 — Posted: 2022-09-30 — Discussion: 2023-01-10  eLife
Two opposing gene expression patterns within ATRX aberrant neuroblastoma
van Gerven, M. R., Schild, L., van Arkel, J., Koopmans, B., Broeils, L. A., Meijs, L. A. M., van Oosterhout, R., van Noesel, M. M., Koster, J., van Hooff, S. R., Molenaar, J. J., van den Boogaard, M.
10.1101/2022.10.25.513663 — Posted: 2022-10-26 — Discussion: 2023-01-05  Review Commons
Oncogenic PKA signaling stabilizes MYC oncoproteins via an aurora kinase A-dependent mechanism
Chan, G. K. L., Maisel, S., Hwang, Y. C., Wolber, R. R. B., Vu, P., Patra, K. C., Bouhaddou, M., Kenerson, H. L., Yeung, R. S., Swaney, D. L., Krogan, N. J., Turnham, R. E., Scott, J. D., Riehle, K. J., Bardeesy, N., Gordan, J. D.
10.1101/2021.04.16.438110 — Posted: 2021-04-16 — Discussion: 2023-01-02  eLife
Dalpiciclib Partially Abrogates ER Signaling Activation Induced by Pyrotinib In HER2+HR+ Breast Cancer
Liu, C., Bu, J., Zhang, Y., Niu, N., Bi, K., Sun, L., Qiao, X., Wang, Y., Zhang, Y., Jiang, X., Wang, D., Ma, Q., Li, H.
10.1101/2022.12.07.519433 — Posted: 2022-12-11 — Discussion: 2023-01-02  eLife
Elys deficiency constrains Kras-driven tumour burden by amplifying oncogenic stress
Morgan, K. J., Doggett, K., Geng, F.-S., Whitehead, L., Smith, K. A., Hogan, B. M., Simons, C., Baillie, G. J., Molania, R., Papenfuss, A. T., Hall, T. E., Ober, E. A., Stainier, D. Y. R., Gong, Z., Heath, J. K.
10.1101/2021.08.25.457580 — Posted: 2021-08-27 — Discussion: 2022-12-30  eLife
EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry
Luan, H., Bielecki, T. A., Mohapatra, B. C., Islam, N., Mushtaq, I., Bhat, A. M., Mirza, S., Chakraborty, S., Raza, M., Storck, M. D., Meza, J. L., Thoreson, W. B., Coulter, D. W., Rakha, E., Band, V., Band, H.
10.1101/2022.06.21.497035 — Posted: 2022-06-25 — Discussion: 2022-12-19  eLife
Adrenal cortex size, homeostasis and tumorigenesis is regulated by gonadal hormones via androgen receptor/β-catenin signalling crosstalk.
Lyraki, R., Grabek, A., Tison, A., Peitzsch, M., Bechmann, N., Youssef, S., de Bruin, A., Bakker, E., Claessens, F., Chaboissier, M.-C., Schedl, A.
10.1101/2022.06.23.497219 — Posted: 2022-06-26 — Discussion: 2022-12-16  Review Commons

Evaluation Sources